| 产品描述: | GSK484 HCl 是苯并咪唑的衍生物,是一种选择性的、可逆的 peptidylarginine deiminase 4 (PAD4) 的抑制剂,在无钙的情况下IC50值为50 nM |
| 靶点: |
PAD4(in the absence of Calcium):50 nM;PAD |
| 体外研究: |
GSK484 also inhibits PAD4 citrullination (at 0.2 mM calcium) of benzoyl-arginine ethyl ester (BAEE) substrate in a concentration-dependent manner, as detected using an NH3 release assay. GSK484 causes a clear, statistically-significant reduction in diffused NETs |
| 体内研究: |
GSK484 prevents tumor-induced NETosis in vivo and can antagonize kidney injury in mice with mammary carcinoma or pancreatic neuroendocrine tumors |
| 细胞实验: |
Cell lines: NB4 cells, HEK293 cells Concentrations: 10 μM, 100 μM Incubation Time: 20 min Method: HEK293 cells stably expressing N-terminal FLAG-tagged PAD1, PAD2, PAD3 or PAD4 are engineered by retroviral transduction. Cells are grown in 15 cm diameter plates to subconfluency in DMEM supplemented with 10% Foetal Bovine Serum, harvested by centrifugation and washed once in PBS/2 mM EGTA. Cells are lysed in 50 mM Tris-Cl, pH 7.4, 1.5 mM MgCl2, 5% glycerol, 150 mM NaCl, 25 mM NaF, 1 mM Na3VO4, 0.4% NP40, 1 mM DTT with protease inhibitors. Lysates are pre-incubated for 20 min at 4℃ with DMSO alone (2%) or 100 μM of GSK484. Citrullination reactions are performed for 30 min at 37℃ in the presence of 2 mM calcium. |
| 动物实验: |
Animal Models: MMTV-PyMT mouse model (FVB) and RIP1-Tag2 mouse model (C57BL) Dosages: 4 mg/kg Administration: IP |
| 参考文献: |
1. Huw D Lewis, et al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. 2015 Mar;11(3):189-91. 2. Jessica Cedervall, et al. Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice. Oncoimmunology. 2017 Apr 20;6(8):e1320009. |
| 溶解性: |
Soluble in DMSO、Ethanol、H2O |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.961 ml |
9.803 ml |
19.607 ml |
| 5 mM |
0.392 ml |
1.961 ml |
3.921 ml |
| 10 mM |
0.196 ml |
0.98 ml |
1.961 ml |
| 50 mM |
0.039 ml |
0.196 ml |
0.392 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |